BDNF polymorphism and association with bipolar disorder
US6458541B1 · kind B1 · utility
1Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 11, 2000 |
| Grant date | Oct 1, 2002 |
| Priority date | — |
| Expiry date | Aug 11, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for diagnosing and treating neuropsychiatric disorders, especially bipolar disorder, and to methods for identifying compounds for use in the diagnosis and treatment of neuropsychiatric disorders are disclosed. Also disclosed are novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of neuropsychiatric disorders such as bipolar disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.